Non-invasive prenatal testing: when results suggests maternal cancer
Abstract: It is now well-established that non-invasive prenatal testing (NIPT), originally designed to screen cell-free DNA (cfDNA) in maternal blood for the presence of common fetal trisomies, can lead to incidental detection of occult maternal malignancies. Retrospective evaluations have demonstrated that the detection of multiple copy number alterations in cfDNA is particularly suggestive of an incipient tumor and that cancer detection rates not only depend on tumor biology but also on applied NIPT technologies and downstream diagnostic investigations. Since the identification of a maternal cancer in pregnancy has implications for both woman and the unborn child, prospective studies are needed to provide evidence on best clinical practices and on clinical utility in terms of patient outcomes.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Non-invasive prenatal testing: when results suggests maternal cancer ; volume:35 ; number:4 ; year:2023 ; pages:285-295 ; extent:11
Medizinische Genetik ; 35, Heft 4 (2023), 285-295 (gesamt 11)
- Creator
-
Lenaerts, Liesbeth
Theunis, Miel
Amant, Frédéric
Vermeesch, Joris R.
- DOI
-
10.1515/medgen-2023-2055
- URN
-
urn:nbn:de:101:1-2023120513070565431716
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lenaerts, Liesbeth
- Theunis, Miel
- Amant, Frédéric
- Vermeesch, Joris R.